Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma.

Abdelsattar ZM, Saddoughi SA, Blackmon SH.

J Thorac Oncol. 2018 Apr;13(4):e64-e65. doi: 10.1016/j.jtho.2017.11.003. No abstract available.

PMID:
29576300
2.

National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.

Saddoughi SA, Abdelsattar ZM, Blackmon SH.

Ann Thorac Surg. 2018 Feb;105(2):432-437. doi: 10.1016/j.athoracsur.2017.09.036. Epub 2017 Dec 7.

PMID:
29223422
3.

Acute aortitis of the ascending aorta.

Saddoughi SA, Abel MD, Maleszewski JJ, Schaff HV.

Interact Cardiovasc Thorac Surg. 2017 Jul 1;25(1):142-144. doi: 10.1093/icvts/ivx059.

PMID:
28369587
4.

Cardiac myxoma: Simplifying a "complex" case.

Saddoughi SA, Maleszewski JJ, Schaff HV.

J Thorac Cardiovasc Surg. 2016 Nov;152(5):1439-1440. doi: 10.1016/j.jtcvs.2016.07.061. Epub 2016 Aug 4. No abstract available.

PMID:
27568826
5.

Survival After Surgical Resection of Stage IV Esophageal Cancer.

Saddoughi SA, Reinersman JM, Zhukov YO, Taswell J, Mara K, Harmsen SW, Blackmon SH, Cassivi SD, Nichols F 3rd, Shen KR, Wigle DA, Allen MS.

Ann Thorac Surg. 2017 Jan;103(1):261-266. doi: 10.1016/j.athoracsur.2016.06.070. Epub 2016 Sep 9.

PMID:
27623270
6.

Surgical Resection of Rare Esophageal Cancers.

Saddoughi SA, Taswell J, Harmsen WS, Inra ML, Blackmon SH, Nichols FC 3rd, Cassivi SD, Wigle DA, Shen KR, Allen MS.

Ann Thorac Surg. 2016 Jan;101(1):311-5. doi: 10.1016/j.athoracsur.2015.06.015. Epub 2015 Aug 13.

PMID:
26277558
7.

Functioning Cooley-Cutter aortic valve prosthesis 40 years after implantation.

Saddoughi SA, Steinberg DH, Ikonomidis JS.

J Thorac Cardiovasc Surg. 2014 Mar;147(3):e21-2. doi: 10.1016/j.jtcvs.2013.10.068. Epub 2013 Nov 27. No abstract available.

8.

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells.

Neviani P, Harb JG, Oaks JJ, Santhanam R, Walker CJ, Ellis JJ, Ferenchak G, Dorrance AM, Paisie CA, Eiring AM, Ma Y, Mao HC, Zhang B, Wunderlich M, May PC, Sun C, Saddoughi SA, Bielawski J, Blum W, Klisovic RB, Solt JA, Byrd JC, Volinia S, Cortes J, Huettner CS, Koschmieder S, Holyoake TL, Devine S, Caligiuri MA, Croce CM, Garzon R, Ogretmen B, Arlinghaus RB, Chen CS, Bittman R, Hokland P, Roy DC, Milojkovic D, Apperley J, Goldman JM, Reid A, Mulloy JC, Bhatia R, Marcucci G, Perrotti D.

J Clin Invest. 2013 Oct;123(10):4144-57. doi: 10.1172/JCI68951. Epub 2013 Sep 3.

9.

Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.

Oaks JJ, Santhanam R, Walker CJ, Roof S, Harb JG, Ferenchak G, Eisfeld AK, Van Brocklyn JR, Briesewitz R, Saddoughi SA, Nagata K, Bittman R, Caligiuri MA, Abdel-Wahab O, Levine R, Arlinghaus RB, Quintas-Cardama A, Goldman JM, Apperley J, Reid A, Milojkovic D, Ziolo MT, Marcucci G, Ogretmen B, Neviani P, Perrotti D.

Blood. 2013 Sep 12;122(11):1923-34. doi: 10.1182/blood-2013-03-492181. Epub 2013 Aug 7. Erratum in: Blood. 2014 May 8;123(19):3056.

10.

Diverse functions of ceramide in cancer cell death and proliferation.

Saddoughi SA, Ogretmen B.

Adv Cancer Res. 2013;117:37-58. doi: 10.1016/B978-0-12-394274-6.00002-9. Review.

PMID:
23290776
11.

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis.

Saddoughi SA, Gencer S, Peterson YK, Ward KE, Mukhopadhyay A, Oaks J, Bielawski J, Szulc ZM, Thomas RJ, Selvam SP, Senkal CE, Garrett-Mayer E, De Palma RM, Fedarovich D, Liu A, Habib AA, Stahelin RV, Perrotti D, Ogretmen B.

EMBO Mol Med. 2013 Jan;5(1):105-21. doi: 10.1002/emmm.201201283. Epub 2012 Nov 25.

12.

Off-target function of the Sonic hedgehog inhibitor cyclopamine in mediating apoptosis via nitric oxide-dependent neutral sphingomyelinase 2/ceramide induction.

Meyers-Needham M, Lewis JA, Gencer S, Sentelle RD, Saddoughi SA, Clarke CJ, Hannun YA, Norell H, da Palma TM, Nishimura M, Kraveka JM, Khavandgar Z, Murshed M, Cevik MO, Ogretmen B.

Mol Cancer Ther. 2012 May;11(5):1092-102. doi: 10.1158/1535-7163.MCT-11-0705. Epub 2012 Mar 27.

13.

Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.

Senkal CE, Ponnusamy S, Manevich Y, Meyers-Needham M, Saddoughi SA, Mukhopadyay A, Dent P, Bielawski J, Ogretmen B.

J Biol Chem. 2011 Dec 9;286(49):42446-58. doi: 10.1074/jbc.M111.287383. Epub 2011 Oct 19.

14.

Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum Cā‚ā‚ˆ-ceramide as a novel biomarker for monitoring response.

Saddoughi SA, Garrett-Mayer E, Chaudhary U, O'Brien PE, Afrin LB, Day TA, Gillespie MB, Sharma AK, Wilhoit CS, Bostick R, Senkal CE, Hannun YA, Bielawski J, Simon GR, Shirai K, Ogretmen B.

Clin Cancer Res. 2011 Sep 15;17(18):6097-105. doi: 10.1158/1078-0432.CCR-11-0930. Epub 2011 Jul 26.

15.

Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.

Salas A, Ponnusamy S, Senkal CE, Meyers-Needham M, Selvam SP, Saddoughi SA, Apohan E, Sentelle RD, Smith C, Gault CR, Obeid LM, El-Shewy HM, Oaks J, Santhanam R, Marcucci G, Baran Y, Mahajan S, Fernandes D, Stuart R, Perrotti D, Ogretmen B.

Blood. 2011 Jun 2;117(22):5941-52. doi: 10.1182/blood-2010-08-300772. Epub 2011 Apr 28.

16.

Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.

Ponnusamy S, Meyers-Needham M, Senkal CE, Saddoughi SA, Sentelle D, Selvam SP, Salas A, Ogretmen B.

Future Oncol. 2010 Oct;6(10):1603-24. doi: 10.2217/fon.10.116. Review.

17.

Direct interaction between the inhibitor 2 and ceramide via sphingolipid-protein binding is involved in the regulation of protein phosphatase 2A activity and signaling.

Mukhopadhyay A, Saddoughi SA, Song P, Sultan I, Ponnusamy S, Senkal CE, Snook CF, Arnold HK, Sears RC, Hannun YA, Ogretmen B.

FASEB J. 2009 Mar;23(3):751-63. doi: 10.1096/fj.08-120550. Epub 2008 Nov 21.

18.

Roles of bioactive sphingolipids in cancer biology and therapeutics.

Saddoughi SA, Song P, Ogretmen B.

Subcell Biochem. 2008;49:413-40. doi: 10.1007/978-1-4020-8831-5_16. Review.

19.

Homoleptic cobalt and copper phenolate A2[M(OAr)4] compounds: the effect of phenoxide fluorination.

Buzzeo MC, Iqbal AH, Long CM, Millar D, Patel S, Pellow MA, Saddoughi SA, Smenton AL, Turner JF, Wadhawan JD, Compton RG, Golen JA, Rheingold AL, Doerrer LH.

Inorg Chem. 2004 Nov 29;43(24):7709-25.

PMID:
15554636
20.

Fractal dimension of velocity signals in high-Reynolds-number hydrodynamic turbulence.

Scotti A, Meneveau C, Saddoughi SG.

Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 1995 Jun;51(6):5594-5608. No abstract available.

PMID:
9963295

Supplemental Content

Loading ...
Support Center